<DOC>
	<DOCNO>NCT02053077</DOCNO>
	<brief_summary>Identification risk GlucoTab system routine use .</brief_summary>
	<brief_title>Risk Identification GlucoTab System Routine Use</brief_title>
	<detailed_description>A study identify risk routine use GlucoTab system glycaemic management non-critically ill patient type 2 diabetes general ward .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>informed consent obtain advised nature study type 2 diabetes newonset hyperglycaemia require s.c. insulin therapy hospital stay diabetes therapy support GlucoTab system type 1 diabetes mellitus intravenous insulin therapy hyperglycaemic episode ( ketoacidosis , hyperosmolar state ) require intravenous insulin therapy gestational diabetes pregnancy know suspected allergy certain insulin type , name user manual total parenteral nutrition ( TPN ) mental condition render patient incapable give consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>